Dr. Mireille Goetghebeur delivered the keynote speech October 5, 2016 at Harvard T.H. Chan School of Public Health ‘Priority Setting in Global Health’ workshop.
Read More
The Division of Health Technology Assessment of the Center for Drug Evaluation in Taipei, Taiwan is implementing the use of the EVIDEM framework for their decision making processes. This initiative is led by Grace Li-Ying Huang (ьSАтТр), Ph.D.
Pilot testing of the EVIDEM framework is ongoing in China, led by Jinsong Geng, from Nantong University. Consultation with decisionmaking and reimbursement experts is ongoing, including from central government level, HTA level, insurance level, and with key stakeholders such as the Cochrane Center in...
A panel discussion on MCDA in South Africa, hosted by the Pharmaceutical Care Management Association, will be held in Johannesburg on June 15th, 2016. For more information see the PCMA event website.
Jinsong Geng of the Medical School of Nantong University, China has joined the EVIDEM Board of Directors. Dr. Jinsong Geng, has been appointed to the position left vacant by Dr. Wagner.
Two posters were presented at the ISPOR 21st Annual International Meeting in Washington, DC on May 21-25: Goetghebeur M, Wagner M, O’Neil B, Samaha D. Can reflective MCDA tackle issues and ethical dilemmas raised by evaluating healthcare interventions for rare diseases: an exploration from...
A panel entitled Multi-criteria decision analysis: A new paradigm in healthcare decisionmaking? What are the current status, challenges and opportunities? was presented at the ISPOR 21st Annual International Meeting. The debate explored whether MCDA can provide a way to change the paradigm in healthcare...
A panel entitled Development of the WHO Priority Medical Devices for Cancer Management took place May 13th, 2016 in collaboration with the World Health Organization WHO at the HTAi 2016 Annual Meeting. Mireille Goetghebeur, Adriana Velazquez and Marjukka Mäkelä discussed the rationale, methods and...